Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Manufactured Housing Properties Inc. Redeems More Than $40 Million in Preferred Stock, Returning Full Capital to Investors
-
Charles River Laboratories to Present at William Blair and Jefferies Conferences
-
MillerKnoll Announces Leadership Transition
-
Starburst Announces Winners of the 2026 AI & Data Visionary Awards at AI & Datanova Miami
-
Palmetto Commercial Properties Promotes Jenna S. Philipp, CCIM, to Partner
-
Aldous Law’s Mother-Daughter Trial Team Wins Big at Elite Trial Lawyers Awards
-
See Alpha and Omega Semiconductor at PCIM 2026 to Learn About Their Advanced AI Core Power, AI Data Center, and Industrial Power Solutions
-
Toshiba Printer Tackles Industrial Labeling
-
Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
-
ACORE CAPITAL Ranks #4 on The PERE Credit 100 List
-
PKWARE Re-Engineers Key Management for Continuous Cryptographic Change
-
WD at Computex 2026: AI Doesn't Just Run on Compute - It Runs on Data
-
Sompo appoints Bart Van Gysegem Country Manager, Insurance for Belgium and the Netherlands
-
Athennian Launches Purpose-Built AI-Governed Platform for Private Markets
-
Genius Group Announces Investor Call to Discuss AI Treasury and AGI Infinity Portfolio
-
House of Doge and Paxos Partner to Expand Global Access to Dogecoin
-
Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026
-
Bitdeer Launches SEALMINER DL1 Hydro Achieving 52.5 GH/s and 149 J/GH Power Efficiency
-
CamdClaw Makes AI-Assisted Quant Trading More Accessible with New Multi-Strategy Platform
-
Ten-League International Holdings Limited Regains Compliance with Nasdaq Bid Price Requirement
-
Agora, Inc. Announces Management Share Purchase Plan
-
SPARC AI Strengthens Board with Appointment of Don Hilton as Independent Non-Executive Director
-
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
-
CredFin, Inc. Launches “250 Businesses by July 4th” Pledge; Honoring 250 Years of the American Dream
-
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
-
Spectral AI Announces Voting Results of Annual Meeting of Stockholders
-
Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors
-
ContextLogic Holdings Inc. Announces Scott Stewart as Chief Financial Officer & Chief Operating Officer
-
zSpace Eliminates Over $12 Million in Debt Through Conversion to Equity
-
Kaltura Named an Exemplary Provider in ISG Research Buyers Guide on Conversational AI
-
Outdoor Holding Company Appoints Director of AI Strategy & Implementation
-
MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology
-
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
-
BCB Appoints New CEO
-
ISG Enhances Technical Depth with Acquisition of R.E. Warner & Associates, a Firm Built on 75 Years of Legacy and Expertise
-
Caring Brands Inc. and SanPellegrino Cosmetics Private Limited Announce Expanded Multi-Territory Licensing Agreement for Photocil and Hair Enzyme Booster
-
GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives
-
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
-
STEALTHGAS INC. Announces the Date for the Release of the First Quarter 2026 Financial and Operating Results, Conference Call and Webcast
-
Vertex to Present at the 46th Annual William Blair Growth Stock Conference
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026
-
NuCana Appoints Ian Webster as Chief Financial Officer
-
Cole West Names Chris Winter President of Homebuilding
-
WTW strengthens North America Outsourcing Sales team with senior industry hires
-
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
-
Blue Sky and Sincerely Jules Bring Vintage Style to Academic Planners at Staples
-
ASML reports transactions under its current share buyback program
-
Kalmar Corporation: Share repurchase during week 22
-
Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis
